Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1

NCT00015028 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Opioid-Related Disorders
Substance-Related Disorders

Interventions

DRUG: Buprenorphine/naloxone

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]